A detailed history of Fifth Third Bancorp transactions in Catalent, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 6,118 shares of CTLT stock, worth $388,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,118
Previous 5,959 2.67%
Holding current value
$388,370
Previous $335,000 10.45%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$56.16 - $60.96 $8,929 - $9,692
159 Added 2.67%
6,118 $370,000
Q2 2024

Jul 22, 2024

BUY
$53.58 - $57.02 $4,661 - $4,960
87 Added 1.48%
5,959 $335,000
Q1 2024

Apr 23, 2024

SELL
$42.56 - $59.82 $959,089 - $1.35 Million
-22,535 Reduced 79.33%
5,872 $331,000
Q4 2023

Jan 19, 2024

SELL
$32.18 - $46.57 $183,458 - $265,495
-5,701 Reduced 16.71%
28,407 $1.28 Million
Q3 2023

Oct 31, 2023

BUY
$44.2 - $50.2 $376,628 - $427,754
8,521 Added 33.3%
34,108 $1.55 Million
Q2 2023

Jul 25, 2023

SELL
$31.86 - $67.26 $162,995 - $344,102
-5,116 Reduced 16.66%
25,587 $1.11 Million
Q1 2023

Apr 24, 2023

BUY
$45.44 - $74.26 $494,069 - $807,428
10,873 Added 54.83%
30,703 $2.02 Million
Q4 2022

Jan 25, 2023

BUY
$41.39 - $81.0 $275,077 - $538,326
6,646 Added 50.41%
19,830 $0
Q3 2022

Oct 25, 2022

BUY
$72.36 - $113.1 $31,910 - $49,877
441 Added 3.46%
13,184 $954,000
Q2 2022

Aug 04, 2022

BUY
$87.2 - $114.05 $949,869 - $1.24 Million
10,893 Added 588.81%
12,743 $1.37 Million
Q1 2022

Apr 19, 2022

BUY
$94.19 - $124.49 $19,685 - $26,018
209 Added 12.74%
1,850 $205,000
Q4 2021

Feb 01, 2022

BUY
$119.57 - $139.07 $50,219 - $58,409
420 Added 34.4%
1,641 $210,000
Q3 2021

Oct 15, 2021

BUY
$109.17 - $142.35 $37,663 - $49,110
345 Added 39.38%
1,221 $162,000
Q2 2021

Aug 06, 2021

BUY
$100.34 - $115.69 $23,780 - $27,418
237 Added 37.09%
876 $95,000
Q1 2021

May 07, 2021

SELL
$101.51 - $125.27 $7,511 - $9,269
-74 Reduced 10.38%
639 $67,000
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $57,453 - $70,485
669 Added 1520.45%
713 $74,000
Q3 2020

Nov 09, 2020

SELL
$72.74 - $92.5 $74,413 - $94,627
-1,023 Reduced 95.88%
44 $4,000
Q2 2020

Aug 05, 2020

BUY
$48.02 - $79.04 $44,370 - $73,032
924 Added 646.15%
1,067 $78,000
Q1 2020

May 05, 2020

SELL
$36.95 - $62.95 $1,625 - $2,769
-44 Reduced 23.53%
143 $7,000
Q4 2019

Feb 14, 2020

BUY
$47.06 - $56.64 $3,058 - $3,681
65 Added 53.28%
187 $11,000
Q3 2019

Nov 14, 2019

BUY
$47.45 - $58.05 $521 - $638
11 Added 9.91%
122 $6,000
Q2 2019

Aug 07, 2019

SELL
$39.26 - $54.21 $34,902 - $48,192
-889 Reduced 88.9%
111 $6,000
Q1 2019

May 14, 2019

BUY
$29.84 - $43.92 $13,726 - $20,203
460 Added 85.19%
1,000 $41,000
Q4 2018

Feb 14, 2019

BUY
$29.95 - $46.34 $16,173 - $25,023
540 New
540 $17,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.